News | May 23, 2021
Orchid Pharma Q4FY21 consolidated loss at Rs. 24.72 Cr
The company reported total income of Rs.455.28 crores during the 12 months period ended March 31, 2021
The company reported total income of Rs.455.28 crores during the 12 months period ended March 31, 2021
Drop in revenue in the fourth quarter is normal as China is shut down for most of the quarter due to the Chinese New Year holiday
The company has posted net loss of Rs. 99.54 crores for the period ended March 31, 2020
Aarti Drugs has reported total income of Rs.2159.30 crores during the 12 months period ended March 31, 2021
The company has reported total income of Rs.19425.58 crores during FY ended March 31, 2021
Eris Lifesciences has reported total income of Rs.1220.57 crores during the 12 months period ended March 31, 2021
It reported total income of Rs.15299.25 crores during the FY ended March 31, 2021
Alembic has reported total income of Rs.83.79 crores during the FY ended March 31, 2021
Glucon-D, Sugar Free, EverYuth Scrub, Peel Off Face Mask and Nycil maintained their leadership positions in-their respective categories as on March 2021.
The company reported total income of Rs.390.05 crores during the 12 months period ended March 31, 2021
Subscribe To Our Newsletter & Stay Updated
